VEGFA and Gorham-Stout disease: Furthermore, this case demonstrates that Propranolol can be safely administered and has striking therapeutic efficacy as a single agent in Gorham’s syndrome by decreasing circulating VEGF-A but not by modifying VEGF-C or FLT-1 levels.